0001209191-17-002446.txt : 20170105 0001209191-17-002446.hdr.sgml : 20170105 20170105210732 ACCESSION NUMBER: 0001209191-17-002446 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170104 FILED AS OF DATE: 20170105 DATE AS OF CHANGE: 20170105 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Zeltiq Aesthetics Inc CENTRAL INDEX KEY: 0001415336 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 270119051 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4698 Willow Road STREET 2: Suite 100 CITY: Pleasanton STATE: CA ZIP: 94588-2710 BUSINESS PHONE: (925) 474-2500 MAIL ADDRESS: STREET 1: 4698 Willow Road STREET 2: Suite 100 CITY: Pleasanton STATE: CA ZIP: 94588-2710 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sullivan Keith J CENTRAL INDEX KEY: 0001417973 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35318 FILM NUMBER: 17512703 MAIL ADDRESS: STREET 1: C/O RELIANT TECHNOLOGIES, INC. STREET 2: 464 ELLIS STREET CITY: MOUNTAIN VIEW STATE: CA ZIP: 94043 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-01-04 0 0001415336 Zeltiq Aesthetics Inc ZLTQ 0001417973 Sullivan Keith J C/O ZELTIQ AESTHETICS, INC. 4410 ROSEWOOD DRIVE PLEASANTON CA 94588 0 1 0 0 CCO, President, North America Common Stock 2017-01-04 4 M 0 8000 6.21 A 87198 D Common Stock 2017-01-04 4 S 0 7700 44.3367 D 79498 D Common Stock 2017-01-04 4 S 0 100 44.89 D 79398 D Common Stock 2017-01-04 4 S 0 100 44.90 D 79298 D Common Stock 2017-01-04 4 S 0 100 44.91 D 79198 D Common Stock 5000 I By Keith J Sullivan (IRA) FCC as custodian Stock Option (Right to Buy) 6.21 2017-01-04 4 M 0 8000 0.00 D 2022-10-04 Common Stock 8000 74000 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.86 to $44.86, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. 25% of the total number of shares subject to the option vested on October 4, 2013, and the remainder vest in equal monthly installments over a 36-month period thereafter, subject to the Reporting Person's continued service to the Issuer. /s/ Sergio Garcia, Attorney-in-Fact 2017-01-05